| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Agrawal Vivek | EVP & Chief Growth Officer | 711 HIGH STREET, DES MOINES | Chris Agbe-Davies as Attorney-in-Fact | 25 Feb 2026 | 0002000397 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFG | Common Stock | Award | $0 | +6,826 | +21% | $0.000000 | 40,064 | 23 Feb 2026 | Direct | F1 |
| transaction | PFG | Common Stock | Award | $0 | +5,960 | +15% | $0.000000 | 46,024 | 23 Feb 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Grant of restricted stock units. |
| F2 | Settlement of performance-based restricted stock units granted 2/27/2023. |